Tessa Therapeutics

OverviewSuggest Edit

Tessa Therapeutics is a biotechnology company specializing in the research, clinical development, and commercialization of cancer immunotherapy treatments. The Company is engaged in employing Virus-Specific T cells to treat cancer, and conducting US FDA-registered Phase III T cell therapy trial in NPC, or any cancer indication.

TypePrivate
Founded2011
HQSingapore, SG
Websitetessatherapeutics.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Sept 2021)182(-1%)
Cybersecurity ratingBMore

Key People/Management at Tessa Therapeutics

Teo Ming Kian

Teo Ming Kian

Chairman
Göran Ando

Göran Ando

Chairman
Jeffrey H. Buchalter

Jeffrey H. Buchalter

Director & CEO
John Ng

John Ng

Chief Operations Officer
Ivan D. Horak

Ivan D. Horak

President of Research and Development
Fidah Alsagoff

Fidah Alsagoff

Director
Show more

Tessa Therapeutics Office Locations

Tessa Therapeutics has an office in Singapore
Singapore, SG (HQ)
8 Temasek Boulevard, #24-02 Suntec Tower 3
Show all (1)

Tessa Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2011

Tessa Therapeutics total Funding

$80 m

Tessa Therapeutics latest funding size

$80 m

Time since last funding

4 years ago

Tessa Therapeutics investors

Tessa Therapeutics's latest funding round in December 2017 was reported to be $80 m. In total, Tessa Therapeutics has raised $80 m
Show all financial metrics

Tessa Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

Tessa Therapeutics Online and Social Media Presence

Embed Graph

Tessa Therapeutics News and Updates

Tessa Therapeutics Announces Collaboration with A*STAR’s Institute of Molecular and Cell Biology to Form Cell Therapy Laboratory

Joint Research Facility to Accelerate the Discovery and Development of Tessa’s Next Generation of Cell Therapies Joint Research Facility to Accelerate the Discovery and Development of Tessa’s Next Generation of Cell Therapies

Tessa Therapeutics Announces Positive, Topline Data from Ongoing Phase 1 Trial of Allogeneic, “Off-the-Shelf” Cell Therapy, in Patients with Relapsed or Refractory CD30-Positive Lymphoma

Data to be Presented Today at the ASGCT 24th Annual Meeting Demonstrated No Dose-Limiting Toxicity with Encouraging Clinical Activity in First 5 Patients Treated; Final Data Readout Expected by End of 2021 Data to be Presented Today at the ASGCT 24th Annual Meeting Demonstrated No Dose-Limiting Toxi…

Tessa Therapeutics Announces Enrollment of 12 Patient Pilot Cohort in its Relapsed or Refractory Hodgkin Lymphoma Phase 2 Study

82 Patient Pivotal cohort expected to commence in second half of 2021 BEDMINSTER, N.J. and SINGAPORE, April 30, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid...

Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial

BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the...

Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy

BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the European Medicines Agency (EMA) has...

Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer

The partnership will leverage Tessa Therapeutics' global operational capabilities and cell therapy platform technologies to target prevalent cancers in China The joint venture will be the sole licensee of Tessa Therapeutics' cell therapies for research, development and commercialization...
Show more

Tessa Therapeutics Blogs

Manager, Finance and Compliance

Excerpt Publication 2 Sample Excerpt The post Manager, Finance and Compliance first appeared on Tessa Therapeutics – Cancer Immunotherapy Treatments.

Associate Manager, Clinical Projects

Excerpt Publication 2 Sample Excerpt The post Associate Manager, Clinical Projects first appeared on Tessa Therapeutics – Cancer Immunotherapy Treatments.

Manager/Lead, Quality Control (Bioanalytical)

Excerpt Publication 2 Sample Excerpt The post Manager/Lead, Quality Control (Bioanalytical) first appeared on Tessa Therapeutics – Cancer Immunotherapy Treatments.

Biotechnologist Lead

Excerpt Publication 2 Sample Excerpt The post Biotechnologist Lead first appeared on Tessa Therapeutics – Cancer Immunotherapy Treatments.

Lead Engineer, Electrical and Instrumentation

Excerpt Publication 2 Sample Excerpt The post Lead Engineer, Electrical and Instrumentation first appeared on Tessa Therapeutics – Cancer Immunotherapy Treatments.

Associate Director/Director, Human Resource (New Jersey)

Excerpt Publication 2 Sample Excerpt The post Associate Director/Director, Human Resource (New Jersey) first appeared on Tessa Therapeutics – Cancer Immunotherapy Treatments.
Show more

Tessa Therapeutics Frequently Asked Questions

  • When was Tessa Therapeutics founded?

    Tessa Therapeutics was founded in 2011.

  • Who are Tessa Therapeutics key executives?

    Tessa Therapeutics's key executives are Teo Ming Kian, Göran Ando and Jeffrey H. Buchalter.

  • How many employees does Tessa Therapeutics have?

    Tessa Therapeutics has 182 employees.

  • Who are Tessa Therapeutics competitors?

    Competitors of Tessa Therapeutics include Gradalis, Immatics and Cryo-Cell.

  • Where is Tessa Therapeutics headquarters?

    Tessa Therapeutics headquarters is located at 8 Temasek Boulevard, #24-02 Suntec Tower 3, Singapore.

  • Where are Tessa Therapeutics offices?

    Tessa Therapeutics has an office in Singapore.

  • How many offices does Tessa Therapeutics have?

    Tessa Therapeutics has 1 office.